InMed Pharmaceuticals Inc (INM)
0.352
+0.01
(+1.50%)
USD |
NASDAQ |
Mar 28, 16:00
0.352
0.00 (0.00%)
After-Hours: 17:01
InMed Pharmaceuticals Cash from Financing (TTM): 4.590M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.590M |
September 30, 2023 | 5.252M |
June 30, 2023 | 10.68M |
March 31, 2023 | 15.73M |
December 31, 2022 | 15.77M |
September 30, 2022 | 9.615M |
June 30, 2022 | 15.07M |
March 31, 2022 | 9.936M |
December 31, 2021 | 14.01M |
September 30, 2021 | 21.80M |
June 30, 2021 | 10.85M |
March 31, 2021 | 10.91M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.1993M |
September 30, 2019 | 0.1989M |
June 30, 2019 | 0.2076M |
March 31, 2019 | 10.61M |
December 31, 2018 | 11.73M |
September 30, 2018 | 18.08M |
June 30, 2018 | 18.62M |
March 31, 2018 | 12.09M |
December 31, 2017 | 13.10M |
Date | Value |
---|---|
September 30, 2017 | 7.797M |
June 30, 2017 | 7.501M |
March 31, 2017 | 3.663M |
December 31, 2016 | 1.448M |
September 30, 2016 | 0.5432M |
June 30, 2016 | 0.3001M |
March 31, 2016 | 1.051M |
December 31, 2015 | 1.666M |
September 30, 2015 | 1.645M |
June 30, 2015 | 1.740M |
March 31, 2015 | 1.534M |
December 31, 2014 | 0.8637M |
September 30, 2014 | 0.7504M |
June 30, 2014 | 0.6464M |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.7887M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.1989M
Minimum
Sep 2019
21.80M
Maximum
Sep 2021
9.715M
Average
10.65M
Median
Cash from Financing (TTM) Benchmarks
Rimrock Gold Corp | 0.2729M |
Venus Concept Inc | 13.77M |
Juva Life Inc | 10.55M |
CEN Biotech Inc | 0.5208M |
Lucy Scientific Discovery Inc | 6.638M |